Week in Review: US Announces Deal with Moderna to Produce 100 Million Doses of Experimental COVID-19 Vaccine

Top news of the week from Pharmacy Times®.

Top news of the week from Pharmacy Times®.

5. Health Care Workers Are at Greater Risk of Mental Health Problems During Pandemic

Health care workers in the United States are struggling with a multitude of challenges during the coronavirus disease 2019 (COVID-19) pandemic and are at greater risk than the general public of experiencing health concerns, such as depression, according to a new study by researchers at North Carolina State University. Read more.

4. Intranasal Vaccine Platform May be More Effective for COVID-19 Vaccine with Fewer Adverse Effects

An intranasal vaccine platform may have the potential to be more effective for vaccine delivery with fewer adverse effects, according to research published in Science Advances. Read more.

3. New Test May Predict Whether Babies Will Develop Type 1 Diabetes

Recent research published in Nature Medicine has found a new approach to predicting which babies will develop type 1 diabetes by combining multiple factors that influence type 1 diabetes risk, according to a press release. Read more.

2. American Pharmacists Association Collaborates With Walmart on Free Opioid Training for All US Pharmacists, Technicians

According to a press release, the customized program includes 6.5 hours of training and education, including a pain management curriculum. Read here.

1. US Announces Deal With Moderna to Produce 100 Million Doses of Experimental COVID-19 Vaccine

If the vaccine doses are used as part of a COVID-19 vaccination campaign, it would be available to Americans at no cost; however, health care providers may charge for the cost of administering the vaccine, according to the US Department of Health and Human Services. Read more.